These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10708715)

  • 1. Responses of the extrapyramidal and limbic substance P systems to ibogaine and cocaine treatments.
    Alburges ME; Ramos BP; Bush L; Hanson GR
    Eur J Pharmacol; 2000 Feb; 390(1-2):119-26. PubMed ID: 10708715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential responses by neurotensin systems in extrapyramidal and limbic structures to ibogaine and cocaine.
    Alburges ME; Hanson GR
    Brain Res; 1999 Feb; 818(1):96-104. PubMed ID: 9914442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems.
    Westwood SC; Hanson GR
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1160-6. PubMed ID: 10027854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibogaine pretreatment dramatically enhances the dynorphin response to cocaine.
    Alburges ME; Hanson GR
    Brain Res; 1999 Nov; 847(1):139-42. PubMed ID: 10564747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD; Pierce RC
    Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of limbic and extrapyramidal substance P systems to nicotine treatment.
    Alburges ME; Frankel PS; Hoonakker AJ; Hanson GR
    Psychopharmacology (Berl); 2009 Jan; 201(4):517-27. PubMed ID: 18773198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cocaine on extrapyramidal and limbic dynorphin systems.
    Smiley PL; Johnson M; Bush L; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1990 Jun; 253(3):938-43. PubMed ID: 1972755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of extrapyramidal and limbic neurotensin systems to phencyclidine treatment.
    Hanson GR; Midgley LP; Bush LG; Gibb JW
    Eur J Pharmacol; 1995 May; 278(2):167-73. PubMed ID: 7672001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic dopaminergic regulation of neuropeptide Y systems in discrete striatal and accumbens regions.
    Midgley LP; Wagstaff JD; Singh NA; Bush LG; Gibb JW; Hanson GR
    Eur J Pharmacol; 1994 Jan; 251(2-3):191-9. PubMed ID: 7908639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats.
    Glick SD; Kuehne ME; Maisonneuve IM; Bandarage UK; Molinari HH
    Brain Res; 1996 May; 719(1-2):29-35. PubMed ID: 8782860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
    Barrett AC; Miller JR; Dohrmann JM; Caine SB
    Neuropharmacology; 2004; 47 Suppl 1():256-73. PubMed ID: 15464142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential involvement of dopamine receptors in conditioned suppression induced by cocaine.
    Grakalic I; Panlilio LV; Thorndike EB; Schindler CW
    Eur J Pharmacol; 2007 Nov; 573(1-3):116-23. PubMed ID: 17628537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats.
    Filip M; Przegaliński E
    Pol J Pharmacol; 1997; 49(1):21-30. PubMed ID: 9431548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience.
    Kosten TA; Zhang XY; Kehoe P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):661-7. PubMed ID: 15845857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptor antagonists fail to prevent induction of cocaine sensitization.
    White FJ; Joshi A; Koeltzow TE; Hu XT
    Neuropsychopharmacology; 1998 Jan; 18(1):26-40. PubMed ID: 9408916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Methyl-D-aspartate receptors mediate dopamine-induced changes in extrapyramidal and limbic dynorphin systems.
    Singh NA; Midgley LP; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1991 Aug; 555(2):233-8. PubMed ID: 1681999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel medications for drug addiction. The legacy of an African shrub.
    Glick SD; Maisonneuve IM
    Ann N Y Acad Sci; 2000; 909():88-103. PubMed ID: 10911925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of haloperidol on release of neurotensin in extrapyramidal and limbic systems.
    Huang W; Hanson GR
    Eur J Pharmacol; 1997 Jul; 332(1):15-21. PubMed ID: 9298921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of SCH-23390 on dopamine D1 receptor occupancy and locomotion produced by intraaccumbens cocaine infusion.
    Neisewander JL; Fuchs RA; O'Dell LE; Khroyan TV
    Synapse; 1998 Oct; 30(2):194-204. PubMed ID: 9723789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.